Drug Report History #4301
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v26-FR | Version v8-EN | |
|---|---|---|
| Language (Changed) | Updated to: French | Was: English |
| Date Updated (Changed) | Updated to: 2020-12-22 | Was: 2017-07-21 |
| Drug Identification Number | 02212234 | 02212234 |
| Brand name | FORTAZ - INJ 6G/VIAL | FORTAZ - INJ 6G/VIAL |
| Common or Proper name | Ceftazidime for injection | Ceftazidime for injection |
| Company Name | GLAXOSMITHKLINE INC | GLAXOSMITHKLINE INC |
| Ingredients | CEFTAZIDIME | CEFTAZIDIME |
| Strength(s) | 6G | 6G |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 6's | 6's |
| Additional packaging sizes | ||
| ATC code | J01DD | J01DD |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Shortage of an active ingredient. | Shortage of an active ingredient. |
| Anticipated start date (Changed) | Updated to: | Was: 2017-07-20 |
| Actual start date (Changed) | Updated to: 2017-07-20 | Was: |
| Estimated end date (Changed) | Updated to: | Was: 2019-01-01 |
| Actual end date (Changed) | Updated to: 2020-12-21 | Was: |
| Shortage status (Changed) | Updated to: Resolved | Was: Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: This product has been discontinued. | Was: FORTAZ® Injection 1g and 2g are available. |
| Health Canada comments |